AnaptysBio, Inc. (ANAB)
54.81
-0.24
(-0.44%)
USD |
NASDAQ |
Mar 02, 16:00
54.81
0.00 (0.00%)
After-Hours: 17:33
AnaptysBio Research and Development Expense (Annual) : 163.23M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Vanda Pharmaceuticals, Inc. | 109.27M |
| Nektar Therapeutics | 119.64M |
| Rigel Pharmaceuticals, Inc. | 23.38M |
| AbbVie, Inc. | 8.249B |
| Esperion Therapeutics, Inc. | 46.24M |